On 19th August the Times published an article on page 19 entitled:
This article by science correspondent Oliver Moody reports on the remarkable impact that Imatinib (Glivec) has had on the lives of many GIST patients and features quotes from our Medical Advisory Board Chair Professor Ian Judson and his colleague Professor Winette van der Graaf from the ICR and the Royal Marsden in London.